Marina Noutsou

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Morten Lindhardt, Frederik Persson, Gemma Currie et al. · BMJ Open · 2016 · 122 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Justyna Siwy, Joost P. Schanstra, Àngel Argilés et al. · Nephrology Dialysis Transplantation · 2014 · 113 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus

Dimitris Tousoulis, Katerina Koniari, Charalambos Antoniades et al. · International Journal of Cardiology · 2009 · 32 citations

Medicine, Endocrinology, Pharmacology +13

Characteristics of high‐ and low‐risk individuals in the <scp>PRIORITY</scp> study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · Diabetic Medicine · 2018 · 27 citations · Full text

Medicine, Chronic Disease Prevention, Nephrology +17